C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2011
10/06/2011	US20110245157 Dimeric 1-arylpyrazole derivatives
10/06/2011	US20110244035 Dosage Forms
10/06/2011	US20110243884 Biodegradable polymer - bioactive moiety conjugates
10/06/2011	US20110243865 Melanin production inhibitor
10/06/2011	US20110243850 Probe for a biological specimen and labelling method and screening method using the probe
10/06/2011	US20110243844 Sulfonamide derivative metabotropic glutamate r4 ligands
10/06/2011	US20110240978 Heterocyclic compound and organic light-emitting device including the same
10/06/2011	US20110240977 Heterocyclic compound and organic light-emitting device including the same
10/06/2011	CA2795110A1 Process for the preparation of dexlansoprazole
10/06/2011	CA2795062A1 Compositions and methods of synthesis of pyridinoylpiperidine 5-ht1f agonists
10/06/2011	CA2795056A1 Salts of dexlansoprazole and their preparation
10/06/2011	CA2794950A1 Cgrp receptor antagonist
10/06/2011	CA2794773A1 Trpv1 vanilloid receptor antagonists with a bicyclic portion
10/06/2011	CA2794676A1 Cytokine inhibitors
10/06/2011	CA2794377A1 2-oxo-dihydropyridine non-nucleoside reverse transcriptase inhibitors
10/06/2011	CA2793897A1 Heterocyclic compounds and their uses
10/06/2011	CA2792068A1 Sweet flavor modifier
10/05/2011	EP2371822A1 Heterobicyclic carboxamides as inhibitors for kinases
10/05/2011	EP2371820A1 Optically active cyclic alcohol compound and method for preparing the same
10/05/2011	EP2371421A1 Ligands of insulin degrading enzyme and their uses
10/05/2011	EP2371366A1 Heterocyclo inhibitors of potassium channel function
10/05/2011	EP2370430A1 N-(1-phenyl-2-arylethyl)-4,5-dihydro-3h-pyrrol-2-amine compounds as subtype selective modulators of alpha2b or alpha2b and alpha2c adrenoceptors
10/05/2011	EP2370429A1 P38 map kinase inhibitors
10/05/2011	EP2370428A1 P38 map kinase inhibitors
10/05/2011	EP2370427A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl]methyl}-2-heteroarylamine derivatives and uses thereof
10/05/2011	EP2370426A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl]methyl}-2-heteroarylamine derivatives and uses thereof
10/05/2011	EP2370425A2 Fused imidazole derivatives as trpv3 antagonist
10/05/2011	EP2370424A1 Compounds useful as inhibitors of atr kinase
10/05/2011	EP2370423A1 Method for preparing a spiroindoline and a precursor thereof
10/05/2011	EP2370416A1 2,4-diaminopyrimidine derivates as ptk2- inhibitors for the treatment of abnormal cell growth
10/05/2011	EP2370413A1 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
10/05/2011	EP2370411A2 Compounds having antiparasitic or anti-infectious activity
10/05/2011	EP2370410A1 2-[(1-cyanopropyl)carbamoyl]-5-chloromethyl nicotinic acids and the use thereof in manufacturing herbicidal imidazolinones
10/05/2011	EP2370407A1 Carbazole and carboline kinase inhibitors
10/05/2011	EP2370111A1 Probe for a biological specimen and labelling method and screening method using the probe
10/05/2011	EP2297118B1 N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperaz ine derivatives as lxr modulators
10/05/2011	EP2102186B1 Indoles
10/05/2011	EP1899329B1 Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors
10/05/2011	EP1888558B1 Bicyclic derivatives as modulators of ion channels
10/05/2011	EP1863933B1 Dimeric and trimeric nucleic acid dyes, and associated systems and methods
10/05/2011	EP1858520B1 Quinazolinone t-type calcium channel antagonists
10/05/2011	EP1575940B1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
10/05/2011	CN1938292B Cyclic amine compound and pest control agent
10/05/2011	CN102209718A Carbamate compound or salt thereof
10/05/2011	CN102209714A Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
10/05/2011	CN102209710A Pyrrolidines
10/05/2011	CN102209537A Heterocyclic gamma secretase modulators
10/05/2011	CN102206206A Azabicyclooctane hydroximic acid derivatives, preparation method thereof, and application thereof in medicament
10/05/2011	CN102206205A Preparation method for imatinib
10/05/2011	CN102206204A Benzimidazole compound and medicinal application thereof
10/05/2011	CN102206203A Synthesis of benzimidazole-containing naphthalimide derivatives and applications of benzimidazole-containing naphthalimide derivatives on cancer resistance
10/05/2011	CN102206202A Pyridazinone derivative and synthetic method thereof
10/05/2011	CN102206180A Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
10/05/2011	CN102206172A Substituted diaryl compound and preparation method and antiviral application thereof
10/05/2011	CN101351446B Novel fused pyrrole derivatives
10/05/2011	CN101300229B 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors
10/05/2011	CN101142207B Conversion of 2-pyrazolines to pyrazoles using bromine
10/05/2011	CN101031558B HIV inhibiting 5-heterocyclyl pyrimidines
10/04/2011	US8032873 Computer program code size partitioning system for multiple memory multi-processing systems
10/04/2011	US8030502 Muscarinic M2 receptor antagonists; such as 4-{N-[7-(3-1-carbamoyl-1,1-diphenylmethyl)pyrrolidin-1-yl)hept-1-yl]-N-(isopropyl)amino}-1-(4-methoxypyrid-3-ylmethyl)piperidine; reduced blurred vision, constipation and dry mouth side effects
10/04/2011	US8030497 Benzimidazole derivatives
10/04/2011	US8030495 Cyclopropyl pyrrolidine orexin receptor antagonists
10/04/2011	US8030487 2-amino—5-substituted pyrimidine inhibitors
10/04/2011	US8030341 Dual delta and mu opioid receptor antagonist; 3,6-Bis(Boc-Dmt-Tic-NH-methyl)-2(1H)-pyrazinone
10/04/2011	US8030339 Imidazole derivatives for the treatment of anxiety and related diseases
10/04/2011	US8030334 Organic compounds
10/04/2011	US8030333 Benzimidazole compound crystal
10/04/2011	US8030332 Potassium channel inhibitors
10/04/2011	US8030331 Allosteric modulators of metabotropic glutamate receptors
10/04/2011	US8030324 Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia
10/04/2011	US8030316 Malate salt of (2R)-methyl-1-{3-[2-(3-pyridinyloxy)ethoxy]-2-pyrazinyl}piperazine
10/04/2011	US8030311 Phenylacetamides suitable as protein kinase inhibitors
10/04/2011	US8030309 Viral polymerase inhibitors
10/04/2011	US8030304 Thiazole pyrazolopyrimidines CRF1 receptor antagonists
10/04/2011	US8030302 Amidophenoxyindazoles useful as inhibitors of c-Met
10/04/2011	US8030300 2-pyrrolidinyloxy-substituted pyridine; Alzheimer's disease, Parkinson's disease, dyskinesias, Tourette's syndrome, schizophrenia, attention deficit disorder, anxiety, pain, depression, obsessive compulsive disorder
10/04/2011	US8030295 19,26,27-trinor-1α,25-dihydroxyvitamin D3 compounds
10/04/2011	CA2669481C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels
10/04/2011	CA2507501C 3-aminopyrrolidine derivatives as modulators of chemokine receptors
10/04/2011	CA2491079C Therapeutic piperazine derivatives useful for treating pain
10/04/2011	CA2438520C Phthalazinone-piperidino-derivatives as pde4 inhibitors
10/04/2011	CA2426031C 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
09/2011
09/29/2011	WO2011120053A1 Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof
09/29/2011	WO2011119869A1 Compositions and methods for the treatment of degenerative diseases
09/29/2011	WO2011119858A1 Analogues for the treatment or prevention of flavivirus infections
09/29/2011	WO2011119853A1 Analogues for the treatment or prevention of flavivirus infections
09/29/2011	WO2011119565A1 Imaging agents for detecting neurological disorders
09/29/2011	WO2011118818A1 Amidinoaneline derivative
09/29/2011	WO2011117876A1 An improved process for the preparation of amlodipine free base and acid addition salts thereof
09/29/2011	WO2011117706A1 Alr2 inhibitors and their synthesis from a natural source
09/29/2011	WO2011117382A1 Pyridyltriazoles
09/29/2011	WO2011117381A1 B-raf kinase inhibitors
09/29/2011	WO2011117380A1 Preparation of hydrated polymorphs of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salt
09/29/2011	WO2011117254A1 Piperidine amides as modulators of the ghrelin receptor
09/29/2011	WO2011117163A1 Cyclopentyl - and cycloheptylpyrazoles as fxr modulators
09/29/2011	WO2011116951A1 Pharmaceutically active disubstituted triazine derivatives
09/29/2011	WO2011086531A3 New anti-malarial agents
09/29/2011	WO2011062766A3 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
09/29/2011	WO2010127152A3 Compounds and compositions as microsomal prostaglandin e synthase-1 inhibitors
09/29/2011	US20110237802 Lenalidomide solvates and processes

1 ... 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 ... 1080